{
 "name": "亞果生醫",
 "slug": "tw-6748",
 "aliases": [
  "亞果生醫股份有限公司",
  "ACRO Biomedical",
  "6748"
 ],
 "ticker": "6748",
 "industry": "生技醫療業",
 "website": "www.acrobiomedical.com",
 "summary": "亞果生醫（6748）是興櫃的生技醫療類股公司，2014 年成立，2021 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "亞果生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "ACRO Biomedical",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2021-07-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2014-06-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "謝達仁",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "謝達仁",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 712181980,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "www.acrobiomedical.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：ABCcolla Collagen ADM Scaffold",
   "value": "靜脈／壓力／糖尿病潰瘍及手術、創傷、一二度燒傷之傷口管理｜已取得FDA 510(k)上市許可｜美國",
   "unit": "",
   "as_of": "2024-10-18",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233378.pdf",
   "note": "as_of取FDA決定函發文日；510(k)為實質等同性許可，非新藥核准。原文適用範圍及限制見Indications for Use。"
  },
  {
   "claim": "管線：ABCcolla Bone Matrix",
   "value": "骨缺損填補｜已取得FDA 510(k)上市許可｜美國",
   "unit": "",
   "as_of": "2021-10-08",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf21/K212156.pdf",
   "note": "as_of取FDA決定函發文日；510(k)為實質等同性許可，非新藥核准。原文適用範圍及限制見Indications for Use。"
  },
  {
   "claim": "管線：ABCcolla Bone Graft",
   "value": "骨缺損填補｜已取得FDA 510(k)上市許可｜美國",
   "unit": "",
   "as_of": "2018-02-01",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf17/K171629.pdf",
   "note": "as_of取FDA決定函發文日；510(k)為實質等同性許可，非新藥核准。原文適用範圍及限制見Indications for Use。"
  },
  {
   "claim": "管線：ABCcolla Collagen Matrix",
   "value": "部分／全層傷口、潰瘍、手術與創傷及一二度燒傷之傷口管理｜已取得FDA 510(k)上市許可｜美國",
   "unit": "",
   "as_of": "2017-05-10",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf16/K162348.pdf",
   "note": "as_of取FDA決定函發文日；510(k)為實質等同性許可，非新藥核准。原文適用範圍及限制見Indications for Use。"
  },
  {
   "claim": "管線：瑞晶珂膠原蛋白植入劑",
   "value": "本公告未列細部適應用途｜TFDA第三等級醫材核准上市｜台灣",
   "unit": "",
   "as_of": "2026-05-28",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "公司6748；發言日期：2026-05-28 15:32:28；主旨：公告本公司瑞晶珂 膠原蛋白植入劑獲得衛福部食藥署三類醫材核准上市；衛部醫器製字008783。未將化妝品行銷或未列之用途補成核准適應症。"
  },
  {
   "claim": "管線：ABCcolla Bone Graft（亞比斯可拉骨填料）",
   "value": "本公告未列細部適應用途｜已取得class D醫材上市許可｜印度",
   "unit": "",
   "as_of": "2026-09-18",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "公司6748；發言日期：2026-09-18 15:34:59；主旨：公告本公司亞比斯可拉 骨填料ABCcolla Bone Graft取得印度醫療器材上市許可證；許可證IMP/MD/2022/000728。未從美國510(k)標示外推印度核准用途。"
  },
  {
   "claim": "管線：ABCcolla Collagen ADM Scaffold（亞比斯可拉膠原美粒）",
   "value": "本公告未列細部適應用途｜已取得CLASS 4醫材上市許可｜泰國",
   "unit": "",
   "as_of": "2026-04-13",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "公司6748；發言日期：2026-04-13 15:49:27；主旨：公告本公司亞比斯 可拉 膠原美粒ABCcolla Collagen ADM Scaffold取得泰國醫療器材CLASS 4上市許可；核准字號69-2-1-2-0003204。未由美國許可用途外推泰國範圍。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-6748.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}